Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Orap Forte*


Contraindicated
Extrapyramidal symptoms and / or withdrawal symptoms in neonates exposed during the 3rd trimester of pregnancy

Contraindicated
Orap Forte* :
Type Medicine Non Marketed
Originator B
Agent Mersaco
Distributor Mersaco
Laboratory Janssen
Responsible Party Janssen Pharmaceutica NV
Origin Belgium
Manufacturer Janssen Pharmaceutica NV
Origin Belgium
ATC N05AG02
Revision Date 01/05/2011

Your comment will appear shortly after approval

Orap Forte* :

Revision Date : 01/12/2015


Effect Frequency
Agitation Common
Akathisia Common
Amenorrhoea (amenorrhea) Uncommon
Anorexia Common
Bradykinesia Uncommon
Cephalea Common
Cogwheel rigidity Uncommon
Constipation Common
Depression Common
Dry mouth (Xerostomia) Common
Dysarthria Uncommon
Dyskinesia Uncommon
Dystonia Uncommon
Erectile dysfunction Common
Exhaustion Common
Extrapyramidal disorder Common
Face oedema Uncommon
Galactorrhoea Not known
Glucosuria (Glycosuria) Not known
Grand mal convulsion Not known
Gynecomastia (Gynaecomastia) Not known
Hyperprolactinaemia (Hyperprolactinemia) Not known
Hyponatraemia (Hyponatremia) Not known
Hypothermia Not known
Impatience Common
Insomnia Common
Lethargy Common
Libido decreased Not known
Lightheadedness Very Common
Muscle rigidity Common
Muscle spasms Uncommon
Nausea Common
Neck stiffness /Nuchal rigidity Not known
Neuroleptic malignant syndrome Not known
Nocturia Very Common
Oculogyric crisis Uncommon
Oligomenorrhoea Uncommon
Pollakiuria (Urinary frequency) Common
Pruritus Uncommon
QT interval prolonged (QT prolongation) Not known
Sebaceous gland overactivity Common
Sialorrhea Common
Skin rash Uncommon
Somnolence Very Common
Sweating increased (Excessive sweating) (Hyperhydrosis) Very Common
Tardive dyskinesia Not known
Torsade de pointes Not known
Tremor Common
Urticaria aggravated Not known
Ventricular fibrillation Not known
Ventricular tachycardia Not known
Vision blurred Common
Vomiting Common
Weight increased (weight gain) Common
Withdrawal syndrome neonatal Not known

Different Units By MoH Code

Revision Date : 01/02/2008

Revision Date : 23/05/2011

Orap Forte*  MoH 2615 :
Form Tablet
Packaging Blisters (Al/PVC)
Package Size Box of 20
Strength 4mg
NSSF ✘
Quarantine ✘
Reg. Number 18835
Submission date 01/01/1972
Registration Year 1972
Archived Date 2014


Price Comparison

● Country: The Netherlands
● Package Size: 20
● Public Price: 13.86 EUR ( 1,342,701.36 LBP )
● Pack size unit used: 20
● Cost/Unit: 0,693 EUR ( 0.00 LBP )
● Pharmacy Price: 6.86 EUR ( 664569.36 LBP )
● Reference: Zorginstituut Nederland
● Pricing Date: 15/06/2019
● Type: Medicine Authorised

● Country: Germany
● Package Size: 50
● Public Price: 38.26 EUR ( 3,706,475.76 LBP )
● Pack size unit used: 50
● Cost/Unit: 0,7652 EUR ( 0.00 LBP )
● Pricing Date: 15/05/2021
● Type: Medicine Authorised

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info